Aarti Drugs informs about investment in equity shares of WOS
Aarti Drugs has informed that the Finance & Investment Committee at its Meeting held on Saturday, March 7, 2026, approved the investment in equity shares of Pinnacle Life Science, wholly owned subsidiary (WOS) of the Company, upto an aggregate value of INR 10,00,00,000, by way of subscription to the Rights Issue. The details as required under SEBI Listing Regulations read with SEBI Mater Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed.
The above information is a part of company’s filings submitted to BSE.
